- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana secures SEK 10 million line of credit from largest shareholder
Agartha AB (formerly Adma Förvaltnings AB) currently holds 26 percent of Dignitana shares and has provided the line of credit at market conditions. Under the terms of the agreement Dignitana will have unrestricted access to the funds to support the strategic growth of the company.
“Agartha has been a valued partner to Dignitana for many years now and they share in our vision to offer this life changing scalp cooling therapy to as many patients as possible,” said Dignitana CEO Catarina Mård Löwenadler. “With increasing awareness and progress on reimbursement in our key U.S. market it is an exciting time for scalp cooling, and this financing allows us to accelerate key initiatives to grow the business.”
For More Information Contact
Melissa Bourestom, Chief Communications Officer, firstname.lastname@example.org +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented and patented in 1998 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, email@example.com. Learn more at www.dignitana.com or www.dignicap.com.